Submitted by Anonymous (not verified) on 16 January 2026 - 11:40
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Rivastigmine Sandoz, rivastigmine, Date of authorisation: 10/12/2009, Revision: 19, Status: Authorised